The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs

Cardiovascular dysfunction is one of the most common complications of long-term cancer treatment. Growing evidence has shown that antineoplastic drugs can increase cardiovascular risk during cancer therapy, seriously affecting patient survival. However, little is known about the genetic factors asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Hui, Zuo, Shengkai, Liu, Zipeng, Liu, Huanhuan, Wang, Jianhua, You, Tianyi, Zheng, Zhanye, Zhou, Yao, Qian, Xinyi, Yao, Hongcheng, Xie, Lu, Liu, Tong, Sham, Pak Chung, Yu, Ying, Li, Mulin Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556838/
https://www.ncbi.nlm.nih.gov/pubmed/33055159
http://dx.doi.org/10.1126/sciadv.abb8543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556838/
https://www.ncbi.nlm.nih.gov/pubmed/33055159
http://dx.doi.org/10.1126/sciadv.abb8543

Ejemplares similares